Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals ...

05/20/19

Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion  Nasdaq

Transaction is result of comprehensive capital structure and strategic review conducted independently by both Novelion' s and Aegerion' s Boards of.

[more]